Perbedaan H.M. Sampoerna Tbk. dan Brigit Biofarmaka Teknologi Tbk.: H.M. Sampoerna Tbk. diperdagangkan di Rp730 (kapitalisasi pasar 84,91 T, volume 24 jam 11,27 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: H.M. Sampoerna Tbk. jauh lebih besar — sekitar 515,7× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan H.M. Sampoerna Tbk. lebih aktif diperdagangkan (11,27 jt vs 187,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| HMSP | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 84,91 T | 164,65 M |
Volume | 11,27 jt | 187,4 rb |
Lot | 112,68 rb | 1,87 rb |
Perputaran | 8,26 M | 44,35 jt |
Harga Rata-rata | 733,39 | 236,67 |
Nilai Transaksi | 8,26 M | 44,35 jt |
Harga Ekuilibrium Indikatif | 730 | 242 |
Volume Ekuilibrium Indikatif | 5,51 rb | 500 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.
Selengkapnya di halaman HMSP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →